Review

You have full text access to this OnlineOpen article

T cell epitope–specific immune therapy for rheumatic diseases

  1. Salvatore Albani1,*,
  2. Berent Prakken2

Article first published online: 29 DEC 2005

DOI: 10.1002/art.21520

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 54, Issue 1, pages 19–25, January 2006

Additional Information

How to Cite

Albani, S. and Prakken, B. (2006), T cell epitope–specific immune therapy for rheumatic diseases. Arthritis & Rheumatism, 54: 19–25. doi: 10.1002/art.21520

Author Information

  1. 1

    University of California San Diego, and Androclus Therapeutics, San Diego, California

  2. 2

    University Medical Center Utrecht, and Wilhelmina Children's Hospital, Utrecht, The Netherlands

*Departments of Medicine and Pediatrics, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0663

Publication History

  1. Issue published online: 29 DEC 2005
  2. Article first published online: 29 DEC 2005
  3. Manuscript Accepted: 21 SEP 2005
  4. Manuscript Received: 29 MAR 2005

Funded by

  • NIH. Grant Numbers: 5P50-AR-44850-04, N01-AR-9-2241, 2R01-AI-41721-05, 1R01-AR-48084-01
  • Dutch Organization for Scientific Research NWO VIDI
  • Fifth European Framework

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (66K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Salvatore Albani, Eva C. Koffeman, Berent Prakken, Induction of immune tolerance in the treatment of rheumatoid arthritis, Nature Reviews Rheumatology, 2011, 7, 5, 272

    CrossRef

  2. 2
    Austin Vaz, Jeffrey Lisse, Warren Rizzo, Salvatore Albani, Discussion: DMARDs and biologic therapies in the management of inflammatory joint diseases, Expert Review of Clinical Immunology, 2009, 5, 3, 291

    CrossRef

  3. 3
    Eva C. Koffeman, Mark Genovese, Diane Amox, Elissa Keogh, Ernesto Santana, Eric L. Matteson, Arthur Kavanaugh, Jerry A. Molitor, Michael H. Schiff, James O. Posever, Joan M. Bathon, Alan J. Kivitz, Rodrigo Samodal, Francis Belardi, Carolyn Dennehey, Theo van den Broek, Femke van Wijk, Xiao Zhang, Peter Zieseniss, Tho Le, Berent A. Prakken, Gary C. Cutter, Salvatore Albani, Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial, Arthritis & Rheumatism, 2009, 60, 11
    Direct Link:
  4. 4
    Huib de Jong, Floris F. P. Lafeber, Wilco de Jager, Margje H. Haverkamp, Wietse Kuis, Johannes W. J. Bijlsma, Berent J. Prakken, Salvatore Albani, PAN–DR-Binding Hsp60 self epitopes induce an interleukin-10–mediated immune response in rheumatoid arthritis, Arthritis & Rheumatism, 2009, 60, 7
    Direct Link:
  5. 5
    Martin Braddock, 11th Annual Inflammatory and Immune Diseases Drug Discovery and Development Summit, Expert Opinion on Investigational Drugs, 2007, 16, 6, 909

    CrossRef

  6. 6
    Berent Prakken, Salvatore Albani, Exploiting T cell crosstalk as a vaccination strategy for rheumatoid arthritis, Arthritis & Rheumatism, 2007, 56, 2
    Direct Link:
  7. 7
    Angelo Ravelli, Alberto Martini, Juvenile idiopathic arthritis, The Lancet, 2007, 369, 9563, 767

    CrossRef

  8. 8
    Veronika Sharp, Paul J Utz, Technology Insight: can autoantibody profiling improve clinical practice?, Nature Clinical Practice Rheumatology, 2007, 3, 2, 96

    CrossRef

  9. 9
    Berent J. Prakken, Salvatore Albani, Willem van Eden, Translating immunological tolerance into therapy, European Journal of Immunology, 2007, 37, 9
    Direct Link:
  10. 10
    Marloes W Heijstek, Nico M Wulffraat, Vaccination in autoimmune diseases: a blessing in disguise?, Future Rheumatology, 2007, 2, 2, 153

    CrossRef

  11. 11
    Rebecca ten Cate, Koert Dolman, Pediatrics in Systemic Autoimmune Diseases, 2007,

    CrossRef

  12. 12
    José Luis Pablos Álvarez, Nuevas dianas terapéuticas en artritis reumatoide, Reumatología Clínica, 2006, 2, S9

    CrossRef

View Full Article (HTML) Get PDF (66K)